Resource Hub - Hospitals & Clinicians

Ohio hospitals have been at the forefront of collaborations aimed at addressing the estimated 110,000 Ohioans currently suffering with an addiction to opioids. The OHA Opioid Response Initiative’s three focus areas are prevention, transition to treatment and recovery, and harm reduction. To this end, we have assembled resources for hospitals and clinicians that include guidelines, order sets and protocols.

Opioid Response Initiative
Buprenorphine/Suboxone Waiver Training Resources
Additional Clinical Resources

Opioid Response Initiative
OHA pinpointed communities and hospitals disproportionately affected by the opioid epidemic. Leading experts from the state’s most highly impacted hospitals assembled to identify proven interventions from local, regional and national sources with a plan to share statewide. The OHA Opioid Response Initiative work is organized into focus areas around prevention, transition to treatment and recovery and harm reduction and is guided by meaningful patient outcomes.
Efforts in the first year of the ORI focused primarily on harm reduction and community-wide awareness and education.  Initial data show these efforts to have been worthwhile.  We are beginning to see a decline in overdose encounters in most major metropolitan areas in the state from the first half of 2017 compared to the latter half. 

Opioid Response Initiative Roster
(If your hospital would like to join the Opioid Response Initiative, please contact Paul Hicks)
(Photo: Kick-off meeting of the Opioid Response Initiative)
Buprenorphine/Suboxone Waiver Training Resources
OHA estimates about 110,000 Ohioans are addicted to opioids. Part of the solution is for prescribers to learn more about how to care for addiction with Medication Assisted Treatment, or MAT. 
The Ohio Department of Mental Health and Addiction Services has partnered with the American Society of Addiction Medicine and the Substance Abuse and Mental Health Services Administration to provide free MAT training for prescribers.  
Congress in 2000 passed the Drug Addiction Treatment Act, or DATA, which permits qualified physicians to treat narcotic dependence with schedules III-V narcotic controlled substances that have been approved by the Food and Drug Administration for that indication. The legislation waives the requirement for obtaining a separate Drug Enforcement Administration registration as a Narcotic Treatment Program. 
The DATA 2000 waiver training, which allows physicians or advanced practice prescribers who complete the course to prescribe buprenorphine, is offered as a 1.5 day in-person training or as an online course. The in-person option provides partial reimbursement to providers for their time.   
Topics covered: 
  • Pathophysiology of opioid addiction 
  • Role of buprenorphine, naltrexone and methadone to aid addiction treatment 
  • Combination of MAT with behavioral health and psychosocial treatment 
Learn more about the Ohio DATA 2009 Waiver Trainings
              Dates for upcoming live trainings
              Online training courses
Learn more about incorporating MAT in physician practices  
Additional Clinical Resources
  • Support for Hospital Opioid Use Treatment Toolkit (SHOUT)
    • Includes: Inpatient Guidelines (Buprenorphine & Methadone), Acute Pain and Perioperative Guidelines, Order Sets, Clinical Opioid Withdrawal Score (COWS) score card, and patient materials
  • Three-Day Opioid Detox Order Set - download here
  • Hospital Consent- Patient and Family Agreement on Opioids - download here
  • Opioid Withdrawal Medication Assisted- Medical Adjunct Therapy - download here
  • Opioid Withdrawal Medication Assisted- Medical Adjunct Therapy- SHOUT Protocol - download here
  • Peripartum Guideline for Post-Cesarean Pain Management for women on opioid maintenance treatment – University of Utah - download here
© 2019 The Ohio Hospital Association. All Rights Reserved.